Epoch Turn At Nanogen? Firm Grows ASR Menu With Stock-Swap Merger
This article was originally published in The Gray Sheet
Executive Summary
Nanogen's $58 mil. purchase of Epoch Biosciences adds real-time PCR reagents to the firm's offerings for research institutions and clinical reference labs